Germany's Medios H1 profit hit by pricing pressure; to buy 74% of Caelo to expand API

Medios AG

12/08/2026 07:08

Overview
Germany specialty pharma firm's H1 revenue rose 8.4% to €1.07 bln
Adjusted EBITDA for H1 fell 5.1% as margins declined and costs rose
Company agreed to acquire 74% of Caelo to expand API platform in Europe

Outlook
Medios now expects 2026 revenue between €2.10 bln and €2.16 bln, up from prior €2.00-2.12 bln forecast
Company lowers 2026 EBITDA pre forecast to €88-92 mln from previous €94-102 mln range
Medios expects further benefits from cost and process improvements over the remainder of 2026

Result Drivers
PRICE PRESSURE - Ongoing price pressure on high-margin products weighed on margins, especially in Pharmaceutical Supply
COST INCREASES - Higher operating expenses more than offset the positive effect of revenue growth
EFFICIENCY MEASURES - Initial benefits from cost optimization program Avanti-Medios! seen in Patient-Specific Therapies segment

Company press release: ID:nEQ37LJnQa

Key Details
Metric
Beat/Miss
Actual
Consensus Estimate
H1 Revenue
 
EUR 1.07 bln
 
H1 Net Income
 
EUR 8.50 mln
 
H1 Cash flow from operating activities
 
EUR 11.2 mln
 
H1 EBITDA
 
EUR 44 mln
 

Analyst Coverage
The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 4 "strong buy" or "buy", 1 "hold" and no "sell" or "strong sell"
The average consensus recommendation for the pharmaceuticals peer group is "buy"
Wall Street's median 12-month price target for Medios AG is €20.00, about 79.5% above its August 11 closing price of €11.14
The stock recently traded at 9 times the next 12-month earnings vs. a P/E of 11 three months ago

Reuters Recommended Reads
Aug 11 - Germany's Dermapharm prelim H1 revenue rises, maintains outlook
Aug 12 - Formycon H1 revenue rises sharply on milestone payments, EBITDA loss narrows
Aug 10 - India's Gland Pharma beats quarterly profit view on strong Europe, US sales

For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact reuters.support@thomsonreuters.com.

(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)